Radiopharm Theranostics (ASX:RAD) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Days Sales Outstanding?

Radiopharm Theranostics's average Accounts Receivable for the six months ended in Dec. 2023 was A$2.26 Mil. Radiopharm Theranostics's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil.

The historical rank and industry rank for Radiopharm Theranostics's Days Sales Outstanding or its related term are showing as below:

ASX:RAD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 100.63 Med: 1185.87 Max: 2271.11
Current: 100.63

During the past 2 years, Radiopharm Theranostics's highest Days Sales Outstanding was 2271.11. The lowest was 100.63. And the median was 1185.87.

ASX:RAD's Days Sales Outstanding is ranked worse than
66.18% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs ASX:RAD: 100.63

Radiopharm Theranostics's Days Sales Outstanding declined from Dec. 2022 (1,292.19) to Dec. 2023 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Radiopharm Theranostics Days Sales Outstanding Historical Data

The historical data trend for Radiopharm Theranostics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Days Sales Outstanding Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Days Sales Outstanding

2,271.11

100.63

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	-	-	1,292.19	-	-

Competitive Comparison of Radiopharm Theranostics's Days Sales Outstanding

For the Biotechnology subindustry, Radiopharm Theranostics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Days Sales Outstanding falls into.

Radiopharm Theranostics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Radiopharm Theranostics's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.056	+	0.105)	/	2 )	/	0.292	*	365
=	0.0805					/	0.292	*	365
=	100.63

Radiopharm Theranostics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.105	+	4.41)	/	2 )	/	0	*	365 / 2
=	2.2575					/	0	*	365 / 2
=	N/A

Radiopharm Theranostics (ASX:RAD) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Radiopharm Theranostics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics (ASX:RAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines